repro drugs Flashcards
GnRH analog w agonist properties when used in pulsatile fashion
leuoprolide
GnRH antagonist when used in continousu fashion
leuoproilde
use of leuprolide
uterine fibroids, endometriosis, precocious puberty, prostate cancer, infertility
other GnRH analgos
nafarelin, goserilin, histerilin
estrogen drugs include
ethinyl estradiol, DES, mestranol
use of estrogen drugs
hypogonaidsm or ovarian failure, menstrual abnomralities, hormone replacement therapy in postmenopausal women; use in men w androgen dependent prostate cancer
SE of estroge ndrugs
increase risk of endometrial cancer (when given w/o progestoerone)
bleeding in postmenopausal women
clear cell adenocarcinoma of vagina in females exposed to DES in utero; increase risk of thrombi
Contraindciatiosn in estrogen drugs
ER+ breast cancer, history of DVT’s
Selective estrogen receptor modulators
clomiphene, tamoxifen, raloxifene
Clomiphene is an antagnoist at estrogen receptors in
hypothalamus
prevents normal feedback inhibition and increase release of LH and FSH from pituitary, which stimulates ovulation
clomphene
treat infertility due to anovulation (PCOS)
clomiphene
SE hot flashes, ovarian enlargement, multiple simulatenous pregnancies, visual disturbances
clomiphene
tamoxifen is an antagnoist at the
breast
tamoxifen is an agonist at the
bone, uterus
Increases risk of thromboembolic events and endometrial cancer
used to treat and prevent recurrence of ER/PR + breast cancer
raloxifene is antagnoist at
breast, uterus
raloxifene is agonist at the
bone
increase risk of thrombooembolic evenrts but no increased risk of endometrial cancer
raloxifene
which estrogen receptor modulater is used to treat osteoporosis
raloxifene
aromatase inhibitors
anastrozole, letrozole, exemestane
inhibit periperhal conversion of androgen to estrogen
aromatase inihbitor
clinical use of aromatase inihbiot
ER+ breast cancer in postmenopausal women